Hyperlipidemia: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 27: Line 27:


[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Recommendations for drug therapy]] | [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]]
[[Hyperlipidemia NCEP recommendations for drug therapy of high-risk hyperlipidemia in children and adolescents | Recommendations for drug therapy]] | [[Hyperlipidemia statins in children and adolescents with hyperlipidemia | Statins]] | [[Hyperlipidemia NCEP guidelines for adjuvant therapies in children and adolescents | Adjuvant therapies]]
'''Pharmacotherapy'''
[[Statins]] | [[Niacin]] | [[Fibrate]] | [[Omega-3 fatty acids]]


==References==
==References==

Revision as of 14:21, 20 November 2011